Conzylum has been acquired by EPAM Systems, Inc.
Conzylum has been sold to EPAM Systems, Inc. (EPAM).
Conzylum is a boutique insurtech software development company that specializes in leveraging AI and advanced technologies to provide cutting-edge solutions. The company provides a comprehensive range of services, including portfolio services, business process optimization, calculation, data management, risk management and cloud management. With a focus on software integration, Conzylum collaborates with insurance firms, acting as a partner in the development and implementation of risk profiles based on extensive data analysis. By harnessing large datasets and advanced algorithms, Conzylum enables insurers to make informed decisions, enhance their underwriting processes and effectively manage risks.
Headquartered in Newtown, Pennsylvania, EPAM is a US-based global provider of software engineering and IT consulting services. Its teams of technologists, strategists and designers deliver powerful digital experiences. The company specializes in 11 industries across 55 countries and regions, delivering innovative solutions to its customers’ most challenging problems.
Oaklins’ team in Switzerland advised Conzylum’s owner and founder on the sell-side process.
Peter Meyer
Founder and CEO, Conzylum
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more